BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoberman A, Paradise JL, Shaikh N, Greenberg DP, Kearney DH, Colborn DK, Rockette HE, Kurs-Lasky M, McEllistrem MC, Zoffel LM, Balentine TL, Barbadora KA, Wald ER. Pneumococcal resistance and serotype 19A in Pittsburgh-area children with acute otitis media before and after introduction of 7-valent pneumococcal polysaccharide vaccine. Clin Pediatr (Phila) 2011;50:114-20. [PMID: 21098526 DOI: 10.1177/0009922810384259] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Halgrimson WR, Chan KH, Abzug MJ, Perkins JN, Carosone-link P, Simões EAF. Incidence of Acute Mastoiditis in Colorado Children in the Pneumococcal Conjugate Vaccine Era. Pediatric Infectious Disease Journal 2014;33:453-7. [DOI: 10.1097/inf.0000000000000138] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 3.1] [Reference Citation Analysis]
2 Kawai K, Adil EA, Barrett D, Manganella J, Kenna MA. Ambulatory Visits for Otitis Media before and after the Introduction of Pneumococcal Conjugate Vaccination. The Journal of Pediatrics 2018;201:122-127.e1. [DOI: 10.1016/j.jpeds.2018.05.047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
3 Harrison CJ. Amoxicillin Is the Most Cost-Effective Therapy for Acute Otitis Media: The Culmination of 40 Years of Research. The Journal of Pediatrics 2017;189:5-8.e1. [DOI: 10.1016/j.jpeds.2017.06.070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhao AS, Boyle S, Butrymowicz A, Engle RD, Roberts JM, Mouzakes J. Impact of 13-valent pneumococcal conjugate vaccine on otitis media bacteriology. International Journal of Pediatric Otorhinolaryngology 2014;78:499-503. [DOI: 10.1016/j.ijporl.2013.12.028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
5 Chappuy H, Keitel K, Gehri M, Tabin R, Robitaille L, Raymond F, Corbeil J, Maspoli V, Bouazza N, Alcoba G, Lacroix L, Manzano S, Galetto-Lacour A, Gervaix A. Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric radiologically confirmed community acquired pneumonia following PCV7 introduction in Switzerland. BMC Infect Dis 2013;13:357. [PMID: 23899390 DOI: 10.1186/1471-2334-13-357] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
6 Martin JM, Simonian A, Muniz G, Green M, Shaikh N. Comparison of Bacterial Culture Results Obtained from Nasopharyngeal and Midturbinate Swabs in Children With Upper Respiratory Tract Infection Symptoms. Pediatr Infect Dis J 2018;37:e275-7. [PMID: 29742648 DOI: 10.1097/INF.0000000000002027] [Reference Citation Analysis]
7 van Deursen AM, van Mens SP, Sanders EA, Vlaminckx BJ, de Melker HE, Schouls LM, de Greeff SC, van der Ende A; Invasive Pneumococcal Disease Sentinel Surveillance Laboratory Group. Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infect Dis 2012;18:1729-37. [PMID: 23092683 DOI: 10.3201/eid1811.120329] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 6.8] [Reference Citation Analysis]
8 Martin JM, Hoberman A, Paradise JL, Barbadora KA, Shaikh N, Bhatnagar S, Shope T, Block SL, Haralam MA, Kurs-Lasky M, Colborn DK, Green M. Emergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media. Pediatr Infect Dis J 2014;33:e286-90. [PMID: 24911895 DOI: 10.1097/INF.0000000000000445] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
9 Wiertsema SP, Kirkham LA, Corscadden KJ, Mowe EN, Bowman JM, Jacoby P, Francis R, Vijayasekaran S, Coates HL, Riley TV, Richmond P. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule. Vaccine 2011;29:5163-70. [PMID: 21621576 DOI: 10.1016/j.vaccine.2011.05.035] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 6.5] [Reference Citation Analysis]
10 Gisselsson-Solén M, Henriksson G, Hermansson A, Melhus A. Effect of pneumococcal conjugate vaccination on nasopharyngeal carriage in children with early onset of acute otitis media - a randomized controlled trial. Acta Otolaryngol 2015;135:7-13. [PMID: 25496176 DOI: 10.3109/00016489.2014.950326] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
11 Esposito S, Principi N. Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children. J Immunol Res 2015;2015:591580. [PMID: 26351648 DOI: 10.1155/2015/591580] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
12 Martin JM, Hoberman A, Shaikh N, Shope T, Onika Bhatnagar S, Block SL, Haralam MA, Kurs-Lasky M, Green M. Changes Over Time in Nasopharyngeal Colonization in Children Under 2 Years of Age at the Time of Diagnosis of Acute Otitis Media (1999-2014). Open Forum Infect Dis 2018;5:ofy036. [PMID: 29588912 DOI: 10.1093/ofid/ofy036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]